Opportunity
Alberta Purchasing #AB-2026-04278
RFP for Lenalidomide and Pomalidomide Oncology Oral Solids
Posted
June 09, 2026
Respond By
July 14, 2026
Identifier
AB-2026-04278
NAICS
424210
HealthPRO Procurement Services Inc. is inviting proposals for the supply of oncology oral solid pharmaceuticals, focusing on Lenalidomide and Pomalidomide, under Contract Cycle Code PS27. - Government Buyer: - HealthPRO Procurement Services Inc. (acting as a group purchasing organization for Canadian healthcare institutions) - Products/Services Requested: - Lenalidomide oral solid pharmaceutical (no part number or quantity specified) - Pomalidomide oral solid pharmaceutical (no part number or quantity specified) - OEMs and Vendors: - No specific OEMs or vendors are named in the notice; opportunity is open to all qualified manufacturers and suppliers of these pharmaceuticals - Unique/Notable Requirements: - RFP documents and amendments are available exclusively through Biddingo.com - No mandatory information sessions or NDAs required for access - Open to all qualified bidders; no restrictions on participation - Managed via Alberta Purchasing Connection - This procurement is for oncology drugs critical to cancer treatment, and the opportunity is accessible to a broad range of pharmaceutical manufacturers and suppliers.
Description
HealthPRO Procurement Services Inc. has posted a Request for Proposal (RFP) for contracts related to oncology oral solids, specifically Lenalidomide and Pomalidomide items under Contract Cycle Code PS27. The procurement documents are accessible via Biddingo.com, where any future amendments will also be posted. The opportunity is open to all qualified bidders, with no mandatory information session or NDA required. Proposals can be submitted via email or hard copy as specified in the documents.